Genprex $GNPX Seeks Clinical Gains with REQORSA in Lung Cancer...
Key Takeaways Genprex is advancing its lead gene therapy candidate, REQORSA, through Phase 1/2 clinical trials for non-small cell lung cancer (Acclaim-1) and small cell lung cancer (Acclaim-3). Early trial...